Hexarelin vs GHRP-6

Overview

Hexarelin and GHRP-6 are both potent growth hormone releasing peptides (GHRPs) that act on the ghrelin receptor. Hexarelin is considered one of the most potent GHRPs for GH release, while GHRP-6 is known for its strong appetite-stimulating effects. Neither is FDA-approved.

Key Facts

Aspect	Hexarelin	GHRP-6
Class	GHRP	GHRP
Structure	6 amino acids	6 amino acids
Target	GHS-R1a	GHS-R1a
FDA Status	Not approved	Not approved
Key Feature	Highest potency	Strong appetite stimulation

Mechanism Comparison

Aspect	Hexarelin	GHRP-6
Primary Receptor	GHS-R1a (ghrelin)	GHS-R1a (ghrelin)
GH Release	Very strong	Strong
Appetite Stimulation	Moderate	Very strong
Cortisol Effect	Increases	Increases
Prolactin Effect	Increases	Increases

Unique Properties

Hexarelin:

• Strongest GH release among GHRPs
• Potential cardioprotective effects (research)
• Desensitization may occur with chronic use
• Less appetite stimulation than GHRP-6

GHRP-6:

• Pronounced ghrelin-like effects
• Strong appetite stimulation (can be benefit or drawback)
• Used in research for food intake studies
• May have gastric protective effects

GH Release Comparison

Parameter	Hexarelin	GHRP-6
GH Increase	4-7x baseline	3-5x baseline
Potency Rank	Highest	High
Time to Peak	15-30 minutes	15-30 minutes
Duration	2-3 hours	2-3 hours

Evidence Comparison

Aspect	Hexarelin	GHRP-6
Human Studies	Moderate	Moderate
Cardiac Research	Some data	Limited
Publication Quality	Low-moderate	Low-moderate
Development Status	Research only	Research only

Notable Research

Hexarelin:

• Studied for cardiac function (some positive signals)
• GH stimulation well-characterized
• Investigated in GH deficiency

GHRP-6:

• Extensively used in appetite/food intake research
• GH stimulation characterized
• Studied for gastric effects

Side Effect Profile

Hexarelin

Effect	Likelihood	Notes
Cortisol increase	Common	Significant elevation
Prolactin increase	Common	May affect hormones
Appetite increase	Moderate	Less than GHRP-6
Water retention	Common	GH-related
Flushing	Common	Post-injection
Desensitization	Concern	With chronic use

GHRP-6

Effect	Likelihood	Notes
Appetite increase	Very common	Pronounced hunger
Cortisol increase	Common	Stress hormone elevation
Prolactin increase	Common	Hormonal effects
Water retention	Common	GH-related
Gastric motility	Common	May cause discomfort
Flushing	Common	Post-injection

Appetite Effects

Aspect	Hexarelin	GHRP-6
Hunger Intensity	Moderate	Strong
Onset	Within 30 min	Within 20 min
Duration	1-2 hours	1-3 hours
Practical Impact	Manageable	Can be difficult

GHRP-6’s appetite stimulation is a key differentiator - beneficial for those needing to increase food intake, problematic for those watching calories.

Desensitization Concerns

Factor	Hexarelin	GHRP-6
Receptor Downregulation	More pronounced	Less pronounced
Time Course	Weeks of use	Variable
Recovery	Washout period	Variable
Cycling Needed	Often recommended	Less critical

Hexarelin may require cycling to maintain efficacy.

Comparative Profile

Effect	Hexarelin	GHRP-6	GHRP-2	Ipamorelin
GH Potency	++++	+++	+++	++
Appetite	++	++++	++	+
Cortisol	++	++	++	+
Prolactin	++	++	++	+
Selectivity	Low	Low	Low	High

Regulatory Status

Aspect	Hexarelin	GHRP-6
FDA Approval	No	No
Development	Research only	Research only
Availability	Research chemical	Research chemical
WADA Status	Prohibited	Prohibited
Quality Control	None (gray market)	None (gray market)

Administration (Research Context)

Aspect	Hexarelin	GHRP-6
Route	Subcutaneous	Subcutaneous

Key Differences

Factor	Hexarelin	GHRP-6
GH Potency	Highest among GHRPs	High
Appetite Effect	Moderate	Very strong
Desensitization	More concerning	Less concerning
Cardiac Research	Some positive data	Limited
Research Use	GH studies	Food intake studies

Practical Considerations

Choose Hexarelin for:

• Maximum GH release (research)
• When appetite increase is unwanted
• Potential cardiac research applications

Choose GHRP-6 for:

• Strong appetite stimulation needed
• Food intake research
• When GH potency can be moderate

Summary

• Hexarelin is the most potent GHRP for GH release but may desensitize with chronic use
• GHRP-6 provides strong GH release with pronounced appetite stimulation
• Both elevate cortisol and prolactin (low selectivity)
• Neither is FDA-approved or has robust safety data
• Hexarelin’s desensitization potential is a unique concern
• GHRP-6’s appetite effect distinguishes it from other GHRPs

---

This comparison is for educational purposes only. Neither peptide is approved for human use. Products sold are unregulated research chemicals with uncertain quality and safety.